Tango Therapeutics, Inc. · NASDAQ:TNGX
Ketchum John B received 4,000 Tango Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 5, 2026 · Filed Jun 8, 2026
On Jun 5, 2026, Ketchum John B (Director) received 4,000 Tango Therapeutics, Inc. shares as an award, leaving 24,937 shares. Filed Jun 8, 2026 (Form 4).
- Awarded
- 4,000 shares
- Holding after
- 24,937 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Award | 4,000 | 24,937 | Direct |
Source
Related
- Tango Therapeutics, Inc.
- Ketchum John B
- Tango Therapeutics, Inc. shareholders
- Form 4 · Ketchum John B · Nov 19, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 16, 2026
- Form 4 · Crystal Adam · Nov 13, 2026
- Schedule 13G/A · FMR LLC · Nov 6, 2026
- Form 4 · Crystal Adam · Nov 4, 2026